MyAverix Finance
US · Healthcare
Actuate Therapeutics, Inc. Common stock (ACTU)
Biotechnology
Actuate Therapeutics, Inc. Common stock (ACTU) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for ACTU
Actuate Therapeutics, Inc. Common stock (ACTU) — FAQ
What is ACTU's P/E ratio?
The price-to-earnings (P/E) ratio for Actuate Therapeutics, Inc. Common stock (ACTU) is 25.00 (data as of 2026-05-23).
Does Actuate Therapeutics, Inc. Common stock pay a dividend?
Dividend yield is not available in the current snapshot for Actuate Therapeutics, Inc. Common stock (ACTU). Check the MyAverix Finance app for the latest dividend data.
What sector is Actuate Therapeutics, Inc. Common stock in?
Actuate Therapeutics, Inc. Common stock (ACTU) is classified in the Healthcare sector (Biotechnology industry).
What exchange is ACTU listed on?
ACTU is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.